[
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Company(NYSE: BMY) dropped from Russell 1000 Defensive Index",
    "summary": "Bristol-Myers Squibb Company dropped from Russell 1000 Defensive Index...",
    "url": "https://finnhub.io/api/news?id=6f16155f757e3ec78a3dfd51f835a39b173275275a7f2a78ecb5f794dd3f2a8d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751239146,
      "headline": "Bristol-Myers Squibb Company(NYSE: BMY) dropped from Russell 1000 Defensive Index",
      "id": 135635971,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "Bristol-Myers Squibb Company dropped from Russell 1000 Defensive Index...",
      "url": "https://finnhub.io/api/news?id=6f16155f757e3ec78a3dfd51f835a39b173275275a7f2a78ecb5f794dd3f2a8d"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb: You Might Wish You Bought More Now (Upgrade)",
    "summary": "Discover why Bristol-Myers Squibb's undervalued stock, strong cash flow, and 5% dividend yield make it an attractive buy despite near-term challenges.",
    "url": "https://finnhub.io/api/news?id=4e66fc2b4388cb070de6d38a5452be40c0ee2d57a269d10dba8f8cf0d6ffd8be",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751187600,
      "headline": "Bristol-Myers Squibb: You Might Wish You Bought More Now (Upgrade)",
      "id": 135631401,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2160008492/image_2160008492.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Discover why Bristol-Myers Squibb's undervalued stock, strong cash flow, and 5% dividend yield make it an attractive buy despite near-term challenges.",
      "url": "https://finnhub.io/api/news?id=4e66fc2b4388cb070de6d38a5452be40c0ee2d57a269d10dba8f8cf0d6ffd8be"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500 Stocks: Screening For Long-Term Winners, My List Of 13",
    "summary": "A shift away from big tech dominance is fueling interest in under-the-radar S&P 500 stocks with alpha potential. Find out why stock-picking is making a comeback.",
    "url": "https://finnhub.io/api/news?id=f8b841b49e467eedbb83f8658fce9de0cf506867c295a73ef82f62f1a87c5e35",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751184000,
      "headline": "S&P 500 Stocks: Screening For Long-Term Winners, My List Of 13",
      "id": 135631200,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1372498517/image_1372498517.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "A shift away from big tech dominance is fueling interest in under-the-radar S&P 500 stocks with alpha potential. Find out why stock-picking is making a comeback.",
      "url": "https://finnhub.io/api/news?id=f8b841b49e467eedbb83f8658fce9de0cf506867c295a73ef82f62f1a87c5e35"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb: Still Challenged, But Some Green Shoots Arrive",
    "summary": "Bristol-Myers Squibb: Still Challenged, But Some Green Shoots Arrive",
    "url": "https://finnhub.io/api/news?id=d9c574e9f69a0bcc8758440f23e1eb10e25fb10c924f0b6bca38ab5aacf49980",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751176222,
      "headline": "Bristol-Myers Squibb: Still Challenged, But Some Green Shoots Arrive",
      "id": 135630435,
      "image": "",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=d9c574e9f69a0bcc8758440f23e1eb10e25fb10c924f0b6bca38ab5aacf49980"
    }
  },
  {
    "ts": null,
    "headline": "Merck: Don't Let Today's Bargain Opportunity Pass You By",
    "summary": "Merck remains a top Big Pharma name with strong leadership, rising sales, and high margins, despite regulatory fears and pressures. Learn why MRK stock is a buy.",
    "url": "https://finnhub.io/api/news?id=ef8150d08e342399dd1513b3199ce82a7da44d655618d5191c837c31591dc9bb",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751168314,
      "headline": "Merck: Don't Let Today's Bargain Opportunity Pass You By",
      "id": 135628039,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1249038014/image_1249038014.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Merck remains a top Big Pharma name with strong leadership, rising sales, and high margins, despite regulatory fears and pressures. Learn why MRK stock is a buy.",
      "url": "https://finnhub.io/api/news?id=ef8150d08e342399dd1513b3199ce82a7da44d655618d5191c837c31591dc9bb"
    }
  }
]